Haploidentical related donor allogeneic hematopoietic stem cell transplantation for patient aged older than 76 years with refractory acute myeloid leukemia

Abstract

Description

Keywords

Aged, Allografts, Hematopoietic stem cell transplantation, Humans, Leukemia, myeloid, acute, Male, Recurrence, Tissue donors, Azacitidine, Cyclophosphamide, Cyclosporine, Cytarabine, Fludarabine, Idarubicin, Mycophenolate mofetil, Acute graft versus host disease, Acute myeloid leukemia, Allogeneic hematopoietic stem cell transplantation, Article, Bone marrow biopsy, Brain hematoma, Brain surgery, Case report, Chronic graft versus host disease, Clinical article, Clinical feature, Computer assisted tomography, Contusion, Disease exacerbation, Dizziness, Dose response, Drug dose reduction, Drug effect, Fatigue, Fever, Flow cytometry, Haploidentical donor, Headache, Human, Human tissue, Induction chemotherapy, Left hemisphere, Leukemia relapse, Minimal residual disease, Multiple cycle treatment, Quality of life, Radiation dose fractionation, Treatment duration, Whole body radiation, Allograft, Blood, Donor, Genetics, Recurrent disease

Citation

Endorsement

Review

Supplemented By

Referenced By